| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |